Age of Red Blood Cells in Premature Infants Study (ARIPI)

NCT00326924 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 377

Last updated 2018-01-19

Study results available
· View outcomes & findings →

Summary

To determine if the age of blood transfused to new borns in the NICU setting has an impact on their outcome.

Conditions

  • Premature Birth

Interventions

BIOLOGICAL

Transfusion

PRBC blood transfusions.

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Dean Fergusson, PhD · OHRI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Minute
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00326924 on ClinicalTrials.gov